Details for New Drug Application (NDA): 016749
✉ Email this page to a colleague
NDA 016749 describes NORLESTRIN 21 1/50, which is a drug marketed by Parke Davis and is included in one NDA. Additional details are available on the NORLESTRIN 21 1/50 profile page.
The generic ingredient in NORLESTRIN 21 1/50 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
The generic ingredient in NORLESTRIN 21 1/50 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 016749
| Tradename: | NORLESTRIN 21 1/50 |
| Applicant: | Parke Davis |
| Ingredient: | ethinyl estradiol; norethindrone acetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.05MG;1MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
